Sculptor Capital’s Envoy Medical COCH Stock Holding History

Sculptor Capital’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-623,204	Closed	-$6.24M	–	575
2022 Q4	$6.24M	Hold	623,204	–	–	0.11%	215
2022 Q3	$6.12M	Buy	623,204 +13,939	+2%	+$137K	0.08%	318
2022 Q2	$5.97M	Hold	609,265	–	–	0.06%	367
2022 Q1	$5.95M	Buy	609,265 +55,339	+10%	+$539K	0.05%	389
2021 Q4	$5.39M	Hold	553,926	–	–	0.05%	339
2021 Q3	$5.38M	Hold	553,926	–	–	0.04%	303
2021 Q2	$5.39M	Buy	+553,926	New	+$5.38M	0.04%	300

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Sculptor Capital's COCH Position: Q1 2023 in Review

Sculptor Capital sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 623,204 shares — an estimated $6.24M sold.

Sculptor Capital first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $6.24M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Sculptor Capital reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Sculptor Capital sold 623,204 Envoy Medical shares in Q1 2023, an estimated $6.24M.
Sculptor Capital first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
Sculptor Capital's Envoy Medical position peaked at $6.24M in Q4 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Sculptor Capital's 13F filing for Q1 2023, filed 16 May 2023.